Zusammenfassung
Das Buruli-Ulkus wird durch Mycobacterium ulcerans, ein salzsäure-alkoholfestes Stäbchenbakterium, verursacht. Es findet sich vorwiegend an den Extremitäten als chronisches Ulkus mit weit unterminierten Rändern und ausgedehnten Nekrosen des subkutanen Fettgewebes. Die Heilungstendenz ist schlecht. Die Infektionskrankheit wird hauptsächlich bei Kleinkindern und Jugendlichen beobachtet. Das Auftreten der Erkrankung ist an eine mittlere Jahrestemperatur von 23°C gebunden; es handelt sich demnach um eine tropische Infektionskrankheit. Das Ulkus wurde, mit Ausnahmen, nur bei Farbigen beschrieben. Die Inkubationszeit der Erkrankung beträgt 4–13 Wochen; ihre Epidemiologie, der Infektionsmodus und die Frage einer Resistenz des Menschen und einer möglichen Immunität sind noch ungeklärt. Im Tierversuch können mit M. ulcerans vorzugsweise Ratten und Mäuse infiziert werden. Als Chemotherapeutikum der Wahl gilt heute das Riminophenazon-Derivat Lampren®.
Summary
Buruli ulcer is caused by Mycobacterium ulcerans, an acid-fast (HCl), alcohol-fast, rodshaped bacillus. It occurs mainly in the extremities as a chronic ulcer with considerably undermined margins and extensive necroses of the subcutaneous fatty tissues. The tendency to heal is poor. The infection is observed principally in small children and juveniles. The appearance of the disease is bound up with a mean annual temperature of 23°C. It is therefore a tropical infectious disease. With exceptions, the ulcer has only been described in coloured persons. The incubation period for the disease is 4 to 13 weeks, its epidemiology, mode of infection and the question of a resistance in humans and a possible immunity are still not known. In animal experiments with M. ulcerans, rats and mice can be infected preferentially. The chemotherapeutic agent of choice today is the riminophenazine derivative, Lamprene.
Schrifttum
Aguilar, P. L., Iturribarria, F. M. u.Middlebrook, G. Un caso de infeccion humana por Mycobacterium ulcerans en el hemisferio occidental. Nota previa. Int. J. Leprosy 21 (1953) 469–476.
Barker, D. J. P., Clancey, J. K., Morrow, R. H. andRao, S. Transmission of Buruli disease. Brit. med. J. (1970/IV) 558 (Correspondence).
Barry, V. C., Belton, J. G., Conalty, M. L., Denneny, J. M., Edward, D. W., O'Sullivan, J. F., Twomey, D. andWinder, F. A new series of phenazines (rimino-compounds) with high antituberculosis activity. Nature, London, 179 (1957) 1013–1015.
Barry, V. C. andConalty, M. L. Antituberculosis activity in the phenazine series. II.N3-substituted anilinoaposafranines (rimino-compounds) and some derivatives. Amer. Rev. Tuberc. 78 (1958) 62–73.
Barry, V. C. andConalty, M. L. The antimycobacterial activity of B 663. Lep. Rev. 36 (1965) 3–7.
Basset. A. Tropical phagedenic ulcer. In: Essays on tropical dermatology. Hrsg. vonR. D. G. Ph. Simons andJ. Marshall, S. 25. 33. Excerpta Medica Foundation, Amsterdam 1969.
Bayley, A. C. Buruli ulcer in Ghana. Brit. Med. J. (1971/II) 401–402 (Correspondence).
Bergey's Manual of Determinative Bacteriology. 7. Aufl., S. 700–701. Baltimore 1957.
Bradley, D. J., Hutt, M. S. R., Revill, W. D. L. andKiryabwire, J. W. M., and the other members of the Uganda Buruli Group: Clinical features and treatment of pre-ulcerative Buruli lesions (Mycobacterium ulcerans infection). Brit. med. J. (1970/II) 390–393.
Browne, S. G. andHogerzeil, L. M. „B 663“ in the treatment of leprosy. Preliminary report of a pilot trial. Lep. Rev. 33 (1962) 6–10.
Browne, S. G. Red and black pigmentation developing during treatment of leprosy with “B 663”. Lep. Rev. 36 (1965) 17–20.
Clancey, J. K., Dodge, O. G., Lunn, H. F. andOduori, M. L. Mycobacterial skin ulcers in Uganda. Lancet (1961/II) 951–954.
Clancey, J. K. Mycobacterial skin ulcers in Uganda: Description of a new Mycobacterium (Mycobacterium buruli). J. Path. Bact. 88 (1964) 175–187.
Connor, D. H. andLunn, H. F. Buruli-ulceration. Arch. Path. 81 (1966) 183–199.
Davey, W. W. Companion to surgery in Africa. Kap. IV, S. 27–28. E. & S. Livingstone Ltd., Edinburgh — London 1968.
De Souza-Araujo, H. C. Possible transmission of Mycobacterium leprae by biting arthropods. Trans. Roy. Soc. Trop. Med. Hyg. 55 (1961) 556–557.
Dodge, O. G. andLunn, H. F. Buruli ulcera: a mycobacerial skin ulcer in an Uganda child. J. Trop. Med. Hyg. 65 (1962) 139–142.
Dodge, O. G. Mycobacterial skin ulcers in Uganda: Histopathological and experimental aspects. J. Path. Bact. 88 (1964) 167–174.
Farber, E. R. andTsang, A. Mycobacterial (“Buruli”) ulcer in a Peace Corps worker. Arch. Surg. 95 (1967) 297–300.
Gray, H. H., Kingma, S. andKok, S. H. Mycobacterial skin ulcers in Nigeria. Trans. Roy. Soc. Trop. Med. Hyg. 61 (1967) 712–714.
Janssens, P. G., Quertinmont, M. J., Sieniawski, J. andGatti, F. Necrotic tropical ulcers and mycobacterial causative agents. Trop. Geograph. Med. 11 (1959) 293–312.
Jelliffe, D. B. Diseases of children in the Subtropics and Tropics. 2nd Edition. S. 621–624. Edward Arnold (Publishers) Ltd., London 1970.
Kieninger, G., Schubert, G. E., Ullmann, U., Höfler, W. u.Fouad, Z. Das Buruli-Ulkus. Z. Tropenmed. Parasit. 23 (1972) 342–355.
Languillon, J. Action de deux nouveaux produits, la thalidomide et le B. 663, sur les formes réactionelles de la maladie de Hansen. Méd. Trop. 29 (1969) 497–503.
Lucas, A. O. Clinical features of Mycobacterium ulcerans infection. Hrsg. vom Department of Preventive and Social Medicine, University College Hospital, Ibadan, Nigeria 1969.
Lunn, H. F. andRees, R. J. Treatment of mycobacterial skin ulcer in Uganda with a Riminophenazine derivative (B 663). Lancet (1964/II) 247–249.
Lunn, H. F. Effects of climate on the localisation and geographic distribution of mycobacterial skin ulcers. Dermatologia Internat. Philadelphia 4 (1965) 111–114.
Lunn, H. F., Connor, D. H., Wilks, N. E., Barnley, G. R., Kamunvi, F., Clancey, J. K. andBee, J. D. A. Buruli (Mycobacterial) ulceration in Uganda. (A new focus of Buruli ulcer in Madi District, Uganda) E. Afr. Med. J. 42 (1965) 275–288.
Mac Callum, P., Tolhurst, J. C., Buckle, G. andSissons, H. A. A new mycobacterial infection in man. J. Path. Bact. 60 (1948) 93–122.
Maegraith, B. Exotic diseases in practice. S. 116. Pitman Press, Bath 1965.
Meissner, G. Vorkommen und Eigenschaften (bakteriologisch und tierexperimentell) von atypischen Mycobakterien. Jber. Borstel 5 (1961) 408–480.
Meissner, G. Nichtklassifizierte Mykobakterien. In: Infektionskrankheiten des Menschen und ihre Erreger. Hrsg. vonA. Grumbach u.O. Bonin. S. 932–953. Georg Thieme Verlag, Stuttgart 1969.
Ngu, V. A. Tropical and other ulcers of the leg. Kap. V. S. 89–93. In: Tropical Surgery. Hrsg. vonS. I. Schwartz, A. O. Adesola, E. A. Elebute andC. G. Rob. McGraw Hill Book Comp., New York 1971.
Pattyn, S. R., Boveroulle, M. T., Gatti, F. u.Vandepitte, J. Étude des souches de Mycobacterium ulcerans isolées au Congo (Léopoldville). Acad. Roy. Sci. d'Outre-Mer Bull. des Séances (1964/VI) 1576–1599.
Pettit, J. S., Marchette, N. J. andRees, R. J. W. Mycobacterium ulcerans infection. Clinical and bacteriological study of the first cases recognized in South East Asia. Brit. J. Dermat. 78 (1966) 187–197.
Reid, I. S. Mycobacterium ulcerans infection: a report of 13 cases at the Port Moresby General Hospital, Papua. Med. J. Aust. 1 (1967) 427–431.
Runyon, E. H. Anonymous mycobacteria in pulmonary disease. Med. Clin. N. Amer. 43 (1959) 273–290.
Shattock, F. M. Mycobacterial skin ulceration. E. Afr. Med. J. 42 (1965) 548–551.
Smith, J. H. Epidemiologic observations on cases of Buruli ulcer seen in a hospital in the Lower Congo. Amer. J. Trop. Med. Hyg. 19 (1970) 657–663.
The Uganda Buruli Group: BCG-vaccination against Mycobacterium ulcerans infection (Buruli ulcer). Lancet (1969/I) 111–115.
The Uganda Buruli Group: Epidemiology of Mycobacterium ulcerans infection (Buruli ulcer) at Kinyara, Uganda. Trans. Roy. Soc. Trop. Med. Hyg. 65 (1971) 763–775.
Timpe, A. andRunyon, E. H. The relationship of atypical acidfast bacteria to human disease. A preliminary report. J. Lab. clin. Med. 44 (1954) 202–209.
Ullmann, U., Kieninger, G. u.Schubert, G. E.: Mikrobiologische und tierexperimentelle Untersuchungen mit Mycobacterium ulcerans (in Vorbereitung).
Author information
Authors and Affiliations
Additional information
Herrn Prof. Dr. med.R.-E. Bader zum 60. Geburtstag.
Rights and permissions
About this article
Cite this article
Kieninger, G., Schubert, G.E., Ullmann, U. et al. Die Infektion des Menschen mit Mycobacterium ulcerans (Buruli-Ulkus). Infection 1, 46–52 (1973). https://doi.org/10.1007/BF01638256
Issue Date:
DOI: https://doi.org/10.1007/BF01638256